scholarly journals Humidification in Very-High-Flow Nasal-Cannula Therapy in an Adult Lung Model

2019 ◽  
Vol 64 (7) ◽  
pp. 809-817 ◽  
Author(s):  
Yusuke Chikata ◽  
Keisuke Morinishi ◽  
Masaji Nishimura
Keyword(s):  
High Flow ◽  
Nasal Cannula ◽  
Lung Model ◽  
High Flow Nasal Cannula ◽  
Adult Lung ◽  
Very High

1044: UNDERSTANDING HIGH-FLOW NASAL CANNULA NONINVASIVELY WITH AN IN VITRO BREATHING INFANT LUNG MODEL

2016 ◽  
Vol 44 (12) ◽  
pp. 337-337 ◽  
Author(s):  
Michelle Gardner ◽  
P. Worth Longest ◽  
Laleh Golshahi
Keyword(s):  
High Flow ◽  
Nasal Cannula ◽  
Lung Model ◽  
High Flow Nasal Cannula

scholarly journals Factors affecting the outcome of the usage of high-flow nasal cannula on severe or critically ill COVID-19 patients: a multicentric study from a developing nation

2021 ◽  
Vol 7 (3) ◽  
pp. 260-272
Author(s):  
Moumita Das ◽  
Shuva Das ◽  
AFM T Bhuiyan ◽  
Sudipta Deb Nath ◽  
Rajdeep Biswas ◽  
...  
Keyword(s):  
Critically Ill ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula ◽  
Biochemical Tests ◽  
Hypoxemic Respiratory Failure ◽  
Acute Hypoxemic Respiratory Failure ◽  
Multicentric Study ◽  
Factors Affecting ◽  
Very High

In resource-constrained settings, High-Flow Nasal Cannula (HFNC) can reduce the burden on mechanical ventilation in COVID-19 induced Acute Hypoxemic Respiratory Failure (AHRF). The aim was to observe the factors those might affect the outcome of the usage of HFNC on severe/critically ill COVID-19 patients. This is a multicentric prospective observational study. We observed rRT-PCR positive severe/critically ill ICU patients requiring HFNC for more than six hours. Statistical analysis was done to correlate between factors and outcome. Weaning from HFNC was successful in 47.5% of patients. The death rate was higher in ≥ 50 years older (56.50%), and patients with asthma (60.57%), COPD (60.00%), and CKD (68.42%). Fever (91.67%), cough (72.5%), and dyspnea (67.5%) were the most common symptoms. Mortality rates were higher for patients with raised blood sugar, creatinine levels. Severely systemic inflammatory response was seen very high for the expired patients. On HFNC, percent saturation of oxygen (SpO2) and partial pressure of oxygen (PaO2) progression was significantly high for the surviving patients requiring less inspired fraction of oxygen (FiO2%). The survival rate was higher for the patients using both HFNC and non-rebreather mask (NRM) concomitantly. While after HFNC- SpO2% and FiO2% were significantly related with outcome of the HFNC only treated patients, duration of hospital stay and on HFNC- FiO2% affected the HFNC + NRM treated patients’ outcome. HFNC could save more lives of critically ill AHRF patients who otherwise might need invasive or noninvasive ventilation. Some biochemical tests were observed to have association with the prognosis of the disease though HFNC was given to all. Survival benefit of dual HFNC and NRM therapy needs future study. Asian J. Med. Biol. Res. 2021, 7 (3), 260-272

High-Flow Nasal Cannula on Neonatal Transport: Table

PEDIATRICS ◽  
2016 ◽  
Vol 137 (Supplement 3) ◽  
pp. 642A-642A
Author(s):  
Vivien Carrion ◽  
Matthew Parrish ◽  
Praveen Chandrasekharan
Keyword(s):  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula ◽  
Neonatal Transport
Sign in / Sign up

Export Citation Format

Share Document